老年重症心力衰竭患者临床疗效剖析.docVIP

老年重症心力衰竭患者临床疗效剖析 　　[摘要] 目的 分析老年重症心力衰竭患者的临床治疗方案及治疗效果。 方法 整群选取该院2014年6月―2015年6月接受治疗重症心力衰竭的老年患者130例作为研究对象，随机分为对照组65例和治疗组65例，对照组患者采用常规抗心力衰竭治疗，治疗组采用美托洛尔与厄贝沙坦氢氯噻嗪治疗，比较两组患者临床疗效和治疗前后LVEF、BNP、NYHA三项指标的变化。 结果 根据两组患者数据比较可知，治疗组治疗总有效率82.61%，而对照组治疗总有效率66.67%，治疗组治疗效果显著优于对照组，差异有统计学意义（P0.05），但治疗后比较差异有统计学意义（P0.05）。 结论 将美托洛尔与厄贝沙坦氢氯噻嗪联合使用治疗老年重症心力衰竭疗效好，安全性高，可以有效改善老年患者生存质量。 　　[关键词] 老年；重症心力衰竭；临床疗效 　　[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742（2016）02（a）-0138-02 　　Analysis of Clinical Curative Effect of Elderly Patients with Severe Heart Failure 　　LI Chang-dao 　　Emergency medical， Jilin People’s Hospital， Changchun， Jilin Province， 130021 China 　　[Abstract] Objective To analyze the clinical treatment plan and treatment effect of elderly patients with severe heart failure. Methods 130 cases of elderly patients with severe heart failure treated in our hospital from June 2014 to June 2015 were selected as the research object and randomly divided into two groups with 65 cases in each， the control group were treated with conventional anti heart failure， the treatment group were treated with metoprolol and Irbesartan and hydrochlorothiazide， the clinical curative effect and the changes of the three indicators of LVEF， BNP and NYHA before and after treatment of the two groups were compared. Results The comparative statistics showed that the total treatment effective rate in the treatment group was obviously better than that in the control group ，（ 82.61% vs 66.67%）， the difference was statistically significant by comparison （P0.05）， there was an obvious difference in the three indicators of LVEF， BNP and NYHA between the two groups after treatment （P0.05）. Conclusion The combined use of metoprolol and Irbesartan and hydrochlorothiazide in treatment of elderly patients with severe heart failure has a better curative effect and the security is high， which can effectively improve the survival quality of elderly patients. 　　[Key words] Elderly； Severe heart failure； Clinical curative effect 　　重症心